Delafloxacin effective for SSI
15 Jul 2021
byAudrey Abella
Delafloxacin is noninferior to best available therapies (BAT) for acute bacterial skin and skin structure infections (ABSSSI), particularly in the subset of surgical site infections (SSI), according to the results of the phase IIIb/IV, observer-blinded DRESS study presented at ECCMID 2021.